| Condensed Consolidated Statements of Cash Flows | |
| Net cash provided by operating activities of continuing operations (Note 3) | |
| Cash flows from investing activities of continuing operations: | |
| Capital expenditures | -22.26M |
| Origination of finance receivables held for investment | -622.37M |
| Collections on finance receivables held for investment | 665.52M |
| Purchases of marketable securities | |
| Sales and redemptions of marketable securities | 0 |
| Net cash provided by (used by) investing activities of continuing operations | 27.54M |
| Cash flows from financing activities of continuing operations: | |
| Proceeds from issuance of medium-term notes | 0 |
| Repayments of securitization debt | -178.92M |
| Net increase in credit facilities and unsecured commercial paper | 392.56M |
| Net change in restricted cash | -9.02M |
| Dividends | -47.31M |
| Purchase of common stock for treasury | -126.41M |
| Excess tax benefits from share-based payments | 14.47M |
| Issuance of common stock under employee stock option plans | 13.89M |
| Net cash used by financing activities of continuing operations | 42.2M |
| Effect of exchange rate changes on cash and cash equivalents of continuing operations | -10.63M |
| Net decrease in cash and cash equivalents of continuing operations | |
| Cash flows from discontinued operations: | |
| Cash flows from operating activities of discontinued operations | |
| Effect of exchange rate changes on cash and cash equivalents of discontinued operations | |
| Net cash used by discontinued operations, total | |
| Net decrease in cash and cash equivalents | -49.38M |
| Cash and cash equivalents: | |
| Cash and cash equivalents - beginning of period | 1.07B |
| Cash and cash equivalents of discontinued operations - beginning of period | |
| Net decrease in cash and cash equivalents | -49.38M |
| Less: Cash and cash equivalents of discontinued operations - end of period | |
| Cash and cash equivalents - end of period | 1.02B |